L

Lumos Diagnostics Holdings Ltd
ASX:LDX

Watchlist Manager
Lumos Diagnostics Holdings Ltd
ASX:LDX
Watchlist
Price: 0.037 AUD Market Closed
Market Cap: 27.7m AUD
Have any thoughts about
Lumos Diagnostics Holdings Ltd?
Write Note

Lumos Diagnostics Holdings Ltd
Investor Relations

Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care (POC) diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2021-07-05. The firm's solutions help healthcare professionals to accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and digital reader platforms. The firm's portfolio of product, technology and service offerings include Point-of-care diagnostic products, Point-of-care readers, Commercial services and Manufacturing services. The firm's products include FebriDx and CoviDx. FebriDx is an all-in-one point-of-care test device that can differentiate a viral from bacterial acute respiratory infection. CoviDx is a rapid immunoassay for the detection of the nucleocapsid protein in nasal swabs (NS), oropharyngeal swabs (OP), and nasopharyngeal swabs (NP) from patients suspected of a Coronavirus-19 (COVID-19) infection.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Douglas Ward
CEO, MD & Director
No Bio Available
Mr. Barrie Lambert
Chief Financial Officer
No Bio Available
Dr. Sacha Dopheide Ph.D.
Chief Technology Officer
No Bio Available
Ms. Jennifer Christiansen
Vice President of Corporate Marketing & Communications
No Bio Available
Ms. Sarah Glubka
Senior Director of Human Resources
No Bio Available
Mr. Paul Kase
Senior Vice President of Commercial Operations
No Bio Available
Ms. Tracy Weimar BA, MBA
Company Secretary
No Bio Available

Contacts

Address
VICTORIA
South Melbourne
96-100 Albert Road, Level 4
Contacts
+61399997729.0
lumosdiagnostics.com